Prospective study of cesarean scar pregnancy associated with increased MCP‑1 and cholesterol synthesis

Wu,Qiongwei; Fan,Jiao; Sheng,Qingjing; He,Xiaoying

doi:10.3892/br.2025.2026

Prospective study of cesarean scar pregnancy associated with increased MCP‑1 and cholesterol synthesis

Authors:
- Qiongwei Wu
- Jiao Fan
- Qingjing Sheng
- Xiaoying He
View Affiliations

Affiliations: Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200120, P.R. China
Published online on: June 26, 2025 https://doi.org/10.3892/br.2025.2026
Article Number: 148
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, it was investigated whether gestational trophoblast localization at the cesarean scar was associated with increased monocyte chemoattractant protein‑1 (MCP‑1) and cholesterol synthesis in women's blood and decidual stromal cells. Patients who underwent abortion at 6‑10 weeks of gestation were divided into three groups: cesarean scar pregnancy (CSP), normal intrauterine pregnancy without history of cesarean section (NP), and normal intrauterine pregnancy after cesarean section (NPACS). Blood and decidual tissue at the localization of the gestational sacs were collected from the patients, and RNA sequencing, PCR and ELISA were used to detect differences in the expression of thrombin receptor protease‑activated receptor‑1 (PAR‑1), MCP‑1, CCR2, chemokine (C‑C motif) receptor 2 (CCR2) and cholesterol synthesis‑related proteins sterol regulatory element‑binding protein 2 (SREBP2), 3‑hydroxy‑3‑methylglutaryl‑CoA reductase (HMGCR) and hydroxy‑methyl‑glutaryl Coenzyme A synthase (HMGCS). The expression of PAR‑1, MCP‑1, CCR2, SREBP2, HMGCR and HMGCS in the blood and the decidual stromal cells at the localization of the gestational sac was significantly higher in women with CSP than in the other two groups of patients, whereas the expression of these molecules between NP group and NPACS were not significantly different, and the total blood cholesterol levels of women with cesarean scar pregnancies were significantly higher than those of the other two groups. The development of CSP was associated with a high cholesterol environment and increased MCP‑1 expression in women.

View Figures

View References

1	Luo L, Ruan X, Li C, Chen S, Hu Q and Mueck AO: Early clinical features and risk factors for cesarean scar pregnancy: A retrospective case-control study. Gynecol Endocrinol. 35:337–341. 2019.PubMed/NCBI View Article : Google Scholar
2	Seow KM, Huang LW, Lin YH, Lin MY, Tsai YL and Hwang JL: Cesarean scar pregnancy: Issues in management. Ultrasound Obstet Gynecol. 23:247–253. 2004.PubMed/NCBI View Article : Google Scholar
3	Li HT, Hellerstein S, Zhou YB, Liu JM and Blustein J: Trends in cesarean delivery rates in China, 2008-2018. JAMA. 323:89–91. 2020.PubMed/NCBI View Article : Google Scholar
4	Miller R, Timor-Tritsch IE and Gyamfi-Bannerman C: Society for Maternal-fetal medicine (SMFM) Consult series #49: Cesarean scar pregnancy. Am J Obstet Gynecol. 222:B2–B14. 2020.PubMed/NCBI View Article : Google Scholar
5	Murray MJ and Lessey BA: Embryo implantation and tumor metastasis: Common pathways of invasion and angiogenesis. Semin Reprod Endocrinol. 17:275–290. 1999.PubMed/NCBI View Article : Google Scholar
6	Obenauf AC and Massagué J: Surviving at a distance: Organ-specific metastasis. Trends Cancer. 1:76–91. 2015.PubMed/NCBI View Article : Google Scholar
7	Han B, Alonso-Valenteen F, Wang Z, Deng N, Lee TY, Gao B, Zhang Y, Xu Y, Zhang X, Billet S, et al: A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth. Mol Ther. 30:672–687. 2022.PubMed/NCBI View Article : Google Scholar
8	Zhang KL, Zhu WW, Wang SH, Gao C, Pan JJ, Du ZG, Lu L, Jia HL, Dong QZ, Chen JH, et al: Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer. Theranostics. 11:6560–6572. 2021.PubMed/NCBI View Article : Google Scholar
9	Grandaliano G, Valente AJ and Abboud HE: A novel biologic activity of thrombin: Stimulation of monocyte chemotactic protein production. J Exp Med. 179:1737–1741. 1994.PubMed/NCBI View Article : Google Scholar
10	Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ and Mantovani A: Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol. 144:975–985. 1994.PubMed/NCBI
11	Chaiworapongsa T, Yoshimatsu J, Espinoza J, Kim YM, Berman S, Edwin S, Yoon BH and Romero R: Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med. 11:362–367. 2002.PubMed/NCBI View Article : Google Scholar
12	Bagot CN, Leishman E, Onyiaodike CC, Jordan F and Freeman DJ: Normal pregnancy is associated with an increase in thrombin generation from the very early stages of the first trimester. Thromb Res. 157:49–54. 2017.PubMed/NCBI View Article : Google Scholar
13	Ghio A, Bertolotto A, Resi V, Volpe L and Di Cianni G: Triglyceride metabolism in pregnancy. Adv Clin Chem. 55:133–153. 2011.PubMed/NCBI View Article : Google Scholar
14	Ferriols E, Rueda C, Gamero R, Vidal M, Payá A, Carreras R, Flores-le Roux JA and Pedro-Botet J: Relationship between lipid alterations during pregnancy and adverse pregnancy outcomes. Clin Investig Arterioscler. 28:232–244. 2016.PubMed/NCBI View Article : Google Scholar : (In Spanish).
15	Xiong M, Wang Q, Zhang X, Wen L and Zhao A: Decidual stromal cells-derived exosomes incurred insufficient migration and invasion of trophoblast by disturbing of β-TrCP-mediated snail ubiquitination and degradation in unexplained recurrent spontaneous abortion. Eur J Med Res. 29(39)2024.PubMed/NCBI View Article : Google Scholar
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
17	Shi JW, Yang HL, Fan DX, Yang SL, Qiu XM, Wang Y, Lai ZZ, Ha SY, Ruan LY, Shen HH, et al: The role of CXC chemokine ligand 16 in physiological and pathological pregnancies. Am J Reprod Immunol. 83(e13223)2020.PubMed/NCBI View Article : Google Scholar
18	Lin Z, Shi JL, Chen M, Zheng ZM, Li MQ and Shao J: CCL2: An important cytokine in normal and pathological pregnancies: A review. Front Immunol. 13(1053457)2022.PubMed/NCBI View Article : Google Scholar
19	Valles CS and Domínguez F: Embryo-endometrial interaction. Chang Gung Med J. 29:9–14. 2006.PubMed/NCBI
20	Sun R, Fang P, Jiang J, Huang C, Wang J, Guo Q, Li H, Wu X, Xie X, Jiang Y, et al: Insulin rescued MCP-1-suppressed cholesterol efflux to large HDL2 particles via ABCA1, ABCG1, SR-BI and PI3K/Akt activation in adipocytes. Cardiovasc Drugs Ther. 36:665–678. 2022.PubMed/NCBI View Article : Google Scholar
21	Blanco-Colio LM, Martín-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P and Egido J: ACTFAST investigators. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: A substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. Am Heart J. 153:881–888. 2007.PubMed/NCBI View Article : Google Scholar
22	Damsky CH, Fitzgerald ML and Fisher SJ: Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest. 89:210–222. 1992.PubMed/NCBI View Article : Google Scholar
23	Jones RL, Hannan NJ, Kaitu'u TJ, Zhang J and Salamonsen LA: Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab. 89:6155–6167. 2004.PubMed/NCBI View Article : Google Scholar
24	Red-Horse K, Drake PM, Gunn MD and Fisher SJ: Chemokine ligand and receptor expression in the pregnant uterus: Reciprocal patterns in complementary cell subsets suggest functional roles. Am J Pathol. 159:2199–2213. 2001.PubMed/NCBI View Article : Google Scholar
25	Roussos ET, Condeelis JS and Patsialou A: Chemotaxis in cancer. Nat Rev Cancer. 11:573–587. 2011.PubMed/NCBI View Article : Google Scholar
26	Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 475:222–225. 2011.PubMed/NCBI View Article : Google Scholar
27	Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE, Melhem MF, Yao Z and Zhang J: Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate. 66:1311–1318. 2006.PubMed/NCBI View Article : Google Scholar
28	Yoshidome H, Kohno H, Shida T, Kimura F, Shimizu H, Ohtsuka M, Nakatani Y and Miyazaki M: Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases. Int J Oncol. 34:923–930. 2009.PubMed/NCBI View Article : Google Scholar
29	Fang WB, Yao M, Brummer G, Acevedo D, Alhakamy N, Berkland C and Cheng N: Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment. Oncotarget. 7:49349–49367. 2016.PubMed/NCBI View Article : Google Scholar
30	Nam JS, Kang MJ, Suchar AM, Shimamura T, Kohn EA, Michalowska AM, Jordan VC, Hirohashi S and Wakefield LM: Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res. 66:7176–7184. 2006.PubMed/NCBI View Article : Google Scholar
31	Cranford TL, Velázquez KT, Enos RT, Bader JE, Carson MS, Chatzistamou I, Nagarkatti M and Murphy EA: Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model. Cancer Biol Ther. 18:85–93. 2017.PubMed/NCBI View Article : Google Scholar
32	Yan L and Sundaram S: Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet. Oncotarget. 7:24792–24799. 2016.PubMed/NCBI View Article : Google Scholar
33	Simons K and Ikonen E: How cells handle cholesterol. Science. 290:1721–1726. 2000.PubMed/NCBI View Article : Google Scholar
34	Russell DW: The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 72:137–174. 2003.PubMed/NCBI View Article : Google Scholar
35	Clendening JW, Pandyra A, Boutros PC, El Ghamrasni S, Khosravi F, Trentin GA, Martirosyan A, Hakem A, Hakem R, Jurisica I and Penn LZ: Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci USA. 107:15051–15056. 2010.PubMed/NCBI View Article : Google Scholar
36	Shimano H: Sterol regulatory element-binding proteins (SREBPs): Transcriptional regulators of lipid synthetic genes. Prog Lipid Res. 40:439–452. 2001.PubMed/NCBI View Article : Google Scholar
37	Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP and Frank PG: Role of cholesterol in the development and progression of breast cancer. Am J Pathol. 178:402–412. 2011.PubMed/NCBI View Article : Google Scholar
38	Sakellakis M, Akinosoglou K, Kostaki A, Spyropoulou D and Koutras A: Statins and risk of breast cancer recurrence. Breast Cancer (Dove Med Press). 8:199–205. 2016.PubMed/NCBI View Article : Google Scholar
39	Manthravadi S, Shrestha A and Madhusudhana S: Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis. Int J Cancer. 139:1281–1288. 2016.PubMed/NCBI View Article : Google Scholar
40	Beckwitt CH, Clark AM, Ma B, Whaley D, Oltvai ZN and Wells A: Statins attenuate outgrowth of breast cancer metastases. Br J Cancer. 119:1094–1105. 2018.PubMed/NCBI View Article : Google Scholar
41	Baek AE, Yu YA, He S, Wardell SE, Chang CY, Kwon S, Pillai RV, McDowell HB, Thompson JW, Dubois LG, et al: The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun. 8(864)2017.PubMed/NCBI View Article : Google Scholar